| Financial Year |
March 31 2023 |
| Monetary Funds |
13,385,235,860.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,800,000.00 |
| Accounts Receivable |
9,043,659,842.00 |
| Advances to Suppliers |
3,541,790,845.00 |
| Other Receivables |
609,883,960.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,913,280,010.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,051,406,838.00 |
| Total Current Assets |
30,553,661,906.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,461,416,826.00 |
| Investment Properties |
363,000,163.00 |
| Fixed Assetes |
61,350,326,015.00 |
| Under-construction Projects |
13,606,945,274.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,231,694,997.00 |
| R&D expenses |
-- |
| Goodwill |
128,097,553.00 |
| Long-Term Deferred and Prepaid Expenses |
99,098,932.00 |
| Deferred Income Tax Assets |
1,532,437,502.00 |
| Other Non-Current Assets |
7,413,681,420.00 |
| Sub-Total of Non-Current Assets |
106,900,002,840.00 |
| Total Assets |
137,453,664,746.00 |
| Short-Term Loans |
18,928,800,655.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,105,094,581.00 |
| Accounts Payable |
5,863,852,611.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
513,702,303.00 |
| Taxes Payable |
284,247,373.00 |
| Interest Payable |
-- |
| Dividend Payable |
9,771,322.00 |
| Other payables |
7,328,166,441.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,127,164,163.00 |
| Other Current Liabilities |
2,768,410,434.00 |
| Sub-Total of Current Liabilities |
41,927,146,328.00 |
| Long-term Loans |
47,230,668,587.00 |
| Bonds Payable |
10,292,954,292.00 |
| Long-Term Accounts Payable |
511,145,417.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
514,557,861.00 |
| Other Non-Current Liabilities |
51,028,167.00 |
| Sub-Total of Non-Current Liabilities |
66,618,277,663.00 |
| Total Liabilities |
108,545,423,991.00 |
| Paid-In Capital(Or Share Stock) |
5,250,283,986.00 |
| Capital Surplus |
4,253,435,373.00 |
| Surplus Reserve |
8,903,515,135.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
397,519,151.00 |
| Minority Stockholder's Interest |
8,638,076,900.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,270,163,855.00 |
| Owner's Equity（Stockholder's Equity） |
28,908,240,755.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
137,453,664,746.00 |
